You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Erythromycin lactobionate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for erythromycin lactobionate and what is the scope of freedom to operate?

Erythromycin lactobionate is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, and Teva Parenteral, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin lactobionate. One supplier is listed for this compound.

Recent Clinical Trials for erythromycin lactobionate

Identify potential brand extensions & 505(b)(2) entrants

Prof Dr Jan TackN/A
Universitaire Ziekenhuizen LeuvenN/A
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3

See all erythromycin lactobionate clinical trials

Pharmacology for erythromycin lactobionate

US Patents and Regulatory Information for erythromycin lactobionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 063253-002 Jul 30, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050609-002 Sep 24, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbott ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 062586-001 Jan 4, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn ERYTHROMYCIN erythromycin lactobionate INJECTABLE;INJECTION 062563-001 Mar 28, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.